More on VERA
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $34.27 |
|
|||
| Open | $34.56 | ||||
| 52 Wk High | $1.18 | ||||
| 52 Wk Low | $0.36 | ||||
| Day High | $34.56 | ||||
| Day Low | $33.08 | ||||
| P/E | 566.67 | ||||
| EPS | $0.06 | ||||
| Volume | 4,191,152 | ||||
- Form 4 Vera Therapeutics, Inc. For: Sep 15 Filed by: Fordyce Marshall
- TD Cowen Reiterates Buy Rating on Vera Therapeutics (VERA)
- Raymond James Reiterates Strong Buy Rating on Vera Therapeutics (VERA)
- Form 8-K Vera Therapeutics, Inc. For: Sep 15
- Vera Therapeutics drug meets all endpoints in two-year IgAN trial
- Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy
- Form 4 Vera Therapeutics, Inc. For: Sep 11 Filed by: Young Joseph R
- Vera Therapeutics (VERA) PT Raised to $83 at JPMorgan
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Vera Therapeutics to Participate at Upcoming Investor Conferences
Entities mentioned with VERA
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- Cowen & Co | View Related Stories »
- JPMorgan | View Related Stories »
- 13G | View Related Stories »
- Show More...
